Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis
Autor: | Gottlieb, Alice B *, Kang, Sewon, Linden, Kenneth G, Lebwohl, Mark, Menter, Alan, Abdulghani, Ahsan A, Goldfarb, Michael, Chieffo, Nicole, Totoritis, Mark C |
---|---|
Zdroj: | In Clinical Immunology 2004 111(1):28-37 |
Databáze: | ScienceDirect |
Externí odkaz: |